Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. GB Sciences, Inc.
  6. News
  7. Summary
    GBLX   US3615441090

GB SCIENCES, INC.

(GBLX)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Gb Sciences, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020

02/16/2021 | 02:16pm EDT

GB Sciences, Inc. announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced operating loss was USD 670,311 compared to USD 1.472 million a year ago. Net loss was USD 593,984 compared to net income of USD 1.344 million a year ago. Basic eps was USD 0 compared to USD 0.01 a year ago. For the nine months, operating loss was USD 1.677 million compared to USD 4.555 million a year ago. Net loss was USD 3.246 million compared to USD 3.745 million a year ago. Basic loss per share was USD 0.01 compared to USD 0.01 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to Basic EPS - Continuing Operations of USD 0 a year ago.


© S&P Capital IQ 2021
All news about GB SCIENCES, INC.
09/14Gb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Rel..
GL
09/14GB Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Rel..
CI
09/09Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C..
GL
08/23GB SCIENCES INC : Other Events (form 8-K)
AQ
08/13GB SCIENCES : Management's Discussion and Analysis of Financial Condition and Re..
AQ
07/06GB SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
07/06Gb Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, ..
CI
06/16GB SCIENCES INC : Change in Directors or Principal Officers (form 8-K)
AQ
06/16GB SCIENCES : Resignation and Appointment of Certain Officers (Form 8-K)
PU
06/16GB Sciences, Inc. Announces Executive Changes
CI
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -3,73 M - -
Net Debt 2021 3,18 M - -
P/E ratio 2021 -4,75x
Yield 2021 -
Capitalization 11,3 M 11,3 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 23
Free-Float 86,5%
Chart GB SCIENCES, INC.
Duration : Period :
GB Sciences, Inc. Technical Analysis Chart | GBLX | US3615441090 | MarketScreener
Income Statement Evolution
Managers and Directors
John Claybron Poss Chairman & Chief Executive Officer
Andrea Small-Howard President, Director & Chief Science Officer
Zach Swarts Chief Financial Officer & Treasurer
Edmond A. DeFrank Independent Director
Gary R. Henrie Secretary
Sector and Competitors
1st jan.Capi. (M$)
GB SCIENCES, INC.-14.90%11
MODERNA, INC.321.80%177 867
LONZA GROUP AG36.36%62 278
IQVIA HOLDINGS INC.43.91%49 407
CELLTRION, INC.-23.26%31 021
SEAGEN INC.-12.32%27 940